Supernus Pharmaceuticals ... (SUPN)

AI Score

Unlock

31.65

-0.09 (-0.28%)

At close: Mar 04, 2025, 2:04 PM

Supernus Pharmaceuticals Balance Sheet Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08
Cash & Equivalents	69.33M	75.05M	93.12M	203.43M	288.64M	181.38M	192.25M	100.3M	90.12M	62.19M	74.34M	82.19M	88.51M	48.54M	23.74M	31.41M	52.88M
Short-Term Investments	384.28M	179.82M	368.21M	136.25M	133.89M	165.69M	163.77M	39.74M	23.72M	28.04M	37.94M	49.21M	48.21M	n/a	8.96M	35.12M	7.5M
Long-Term Investments	n/a	16.62M	93.9M	119.17M	350.36M	591.77M	418.8M	133.64M	75.41M	55.01M	19.82M	8.76M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	31.53M	8.51M	-10M	-36.12M	8.03M	615K	380K	389K	20.19M	391K	6.35M	1.52M	144K	2.11M	4.8M	3.79M	4.09M
Receivables	142.08M	144.16M	165.5M	148.93M	140.88M	87.33M	102.92M	65.59M	41.53M	25.91M	17.27M	5.05M	675K	n/a	158K	3.74M	2.28M
Inventory	54.29M	77.41M	91.54M	85.96M	48.33M	26.63M	25.66M	16.3M	16.8M	12.59M	13.44M	7.15M	1.15M	389K	6.75M	2.35M	6.55M
Other Current Assets	36.09M	16.68M	15.78M	54.04M	37.36M	23.22M	17.78M	13.04M	5.91M	5.26M	7.52M	2.76M	1.13M	466K	6.95M	267K	252.51K
Total Current Assets	686.07M	493.11M	734.15M	601.59M	630.42M	472.64M	493.49M	228.45M	151.4M	105.98M	108.89M	97.16M	91.74M	49.4M	39.81M	72.88M	69.46M
Property-Plant & Equipment	11.54M	42.52M	15.17M	16.95M	37.82M	38.35M	4.09M	5.12M	4.34M	3.87M	2.45M	2.55M	1.42M	1.31M	1.25M	1.86M	1.99M
Goodwill & Intangibles	638.93M	716.91M	819.48M	902.21M	442.25M	24.84M	31.37M	36.02M	16.49M	976K	5.43M	1.16M	683K	912K	1.14M	1.37M	1.6M
Total Long-Term Assets	682M	784.56M	968.36M	1.09B	873.68M	687.64M	484.32M	196.01M	158.16M	82.75M	28.62M	13.83M	2.25M	4.33M	7.2M	7.02M	7.68M
Total Assets	1.37B	1.28B	1.7B	1.69B	1.5B	1.16B	977.81M	424.46M	309.57M	188.73M	137.51M	111M	93.99M	53.73M	47.01M	79.9M	77.13M
Account Payables	4.59M	1.96M	10.54M	9.33M	6.15M	10.14M	3.19M	6.84M	8.05M	4.31M	1.86M	3.14M	2.81M	10.08M	11.26M	6.25M	4.47M
Deferred Revenue	n/a	n/a	49.81M	126.25M	122.43M	144.38M	-2.18M	287K	209K	176K	143K	8.09M	508K	232K	n/a	n/a	n/a
Short-Term Debt	6.89M	8.33M	408.76M	13.72M	12.84M	6.07M	2.18M	4.28M	n/a	-17.14M	n/a	n/a	11.81M	8.18M	n/a	n/a	n/a
Other Current Liabilities	280.92M	279.9M	268.66M	292.33M	226.12M	141.93M	143.6M	95.65M	72.48M	51.95M	25.49M	15.17M	7.86M	1.69M	3.94M	3.79M	3.81M
Total Current Liabilities	292.4M	290.2M	687.96M	315.38M	245.11M	160.59M	161.35M	123M	80.74M	56.1M	27.49M	26.4M	22.98M	18.77M	15.21M	10.03M	8.27M
Long-Term Debt	27.38M	33.2M	36M	420.55M	423.98M	375.61M	329.46M	22.26M	4.17M	7.08M	26.95M	34.39M	11.09M	21.77M	75M	75M	75M
Other Long-Term Liabilities	7.6M	7.8M	42.54M	52.02M	90.16M	28.66M	33.97M	10.58M	31.41M	35.21M	10.44M	15.32M	2.04M	1.4M	1.12M	1.02M	169.62K
Total Long-Term Liabilities	39.94M	65.96M	128.35M	557.92M	514.14M	404.27M	363.44M	33.98M	37.07M	13.76M	38.66M	51.13M	13.44M	25.52M	76.12M	76.02M	75.61M
Total Liabilities	332.34M	356.16M	816.3M	873.3M	759.24M	564.85M	524.79M	156.98M	117.81M	69.86M	66.15M	77.53M	36.42M	44.29M	91.33M	86.06M	83.88M
Total Debt	34.27M	41.53M	437.97M	420.55M	390.33M	375.61M	329.46M	26.54M	4.17M	7.19M	26.95M	34.39M	22.9M	29.49M	75M	75M	75M
Common Stock	56K	55K	54K	53K	53K	53K	52K	51K	50K	49K	43K	40K	31K	14K	2K	6K	5.52K
Retained Earnings	556.43M	482.56M	481.25M	379.92M	326.5M	199.55M	86.49M	-26.82M	-84.29M	-144.64M	-158.66M	-178.53M	-86.25M	-39.97M	-93.79M	-55.32M	-55.78M
Comprehensive Income	-189K	-593K	-3.21M	1.54M	8.97M	7.42M	-3.16M	-747K	-134K	-488K	-154K	n/a	-57K	1K	n/a	2K	-2.15M
Shareholders Equity	1.04B	921.52M	886.2M	815.85M	744.86M	595.43M	453.02M	267.48M	191.75M	118.88M	71.35M	33.46M	57.57M	9.44M	-44.32M	-6.16M	-6.75M
Total Investments	384.28M	196.44M	462.11M	255.41M	484.25M	757.47M	582.57M	173.37M	99.13M	83.05M	57.76M	57.97M	48.21M	n/a	8.96M	35.12M	7.5M